MICROVIABLE
THERAPEUTICS

The human microbiota contains trillions of bacteria that play a key role in human health synthesizing essential compounds, modulating the immune response and providing protection against pathogens.

Microviable Therapeutics is a biotech company developing next generation biotherapeutic products based on human commensal bacteria to improve life quality.

EQUIPO

We have assembled a solid and experienced team with scientific leaders in the microbiome and probiotics field to develop novel class products.

Claudio Hidalgo Cantabrana, PhD

Chief Executive Officer and co-founder

Rafael M. Permuy, MBA

Chief Business Officer and co-founder

Noelia Martínez, PhD

R&D director and co-founder

Abelardo Margolles, PhD

Scientific Advisor and co-founder
Professor of Research at IPLA-CSIC

Susana Delgado, PhD

Scientific Advisor and co-founder
Principal Investigator at IPLA-CSIC

Borja Sánchez, PhD

Scientific Advisor and co-founder
Principal Investigator at IPLA-CSIC

Claudio Hidalgo Cantabrana, PhD

Chief Executive Officer and co-founder

Rafael M. Permuy, MBA

Chief Business Officer and co-founder

Noelia Martínez, PhD

R&D director and co-founder

Rosa del Campo, PhD, MD

Scientific Advisor
Microbiologist at Hospital Ramón y Cajal, Madrid, Spain

Carlos López Otín, PhD, MD

Scientific Advisor
Professor at University of Oviedo, Spain

Claudio Hidalgo Cantabrana, PhD

Chief Executive Officer and co-founder

Rafael M. Permuy, MBA

Chief Business Officer and co-founder

Noelia Martínez, PhD

R&D Director and co-founder

Lucía Guadamuro, PhD

Scientist

Desirée Barrientos

Research Assistant

Ignacio Alberti

Sales & Business Development

INVESTORS

We are thankful and grateful to PadeInvest and the private investors for their support.

SUBSIDIZED PROJECT

                   

MICROVIABLE THERAPEUTICS

CONTACT US

CONTACT